Pay in 4 interest-free payments of $53.12 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
6-{5-[4'-(2-Butyl-4-oxo-1
2 / A tri-antennary 6'-sialyl-LacNAc (6SLN3) N-glycan on an Asn core equipped with a biotin tag through a PEG8 spacer
it is removed by hydrogenolysis or basic hydrolysis during global deprotection
The Nα-Fmoc group is removed under standard piperidine conditions during chain elongation
producing high-avidity binding that substantially exceeds the affinity of monovalent GalNAc ligands and closely mimics the geometry of clinically validated Tri-GalNAc targeting moieties used in approved GalNAc-siRNA therapeutics
GP100150: IgA1(224-231)-Tn(228) Pack Size:1 mg 6-{5-[4'-(2-Butyl-4-oxo-1C42H67N9O18 986. 03 IgA1 synthetic Hinge Region glycopeptide fragment from Ser224 to Pro231 with glycosylation ( GalNAc) at Thr228. The C terminus is carboxylic acid. IgA1(224 231) Tn(228) Immunoglobulin heavy constant alpha 1 (IGHA1); Synthetic Hinge region (Tn) glycopeptide (HP)
US$ 79.99
US$ 185.00
US$ 360.00
US$ 150.00
US$ 34.95
US$ 38.00
US$ 500.00
US$ 118.95
US$ 114.95
US$ 18.95
